International, Small Molecule and Structure Based Drug Design (SBDD)

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

International

Small Molecule

Structure Based Drug Design (SBDD)

Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

The Pharma Data

NOVEMBER 19, 2020

. Structure-based design approach has identified potent compounds for further development as oral treatments for SARS-CoV-2 infection and related human coronaviruses. TOKYO and CAMBRIDGE, England , Nov. TOKYO and CAMBRIDGE, England , Nov. The program was initiated in April 2020. 2016), 59, 6595-6628.

Small Molecule

Small Molecule Structure Based Drug Design (SBDD) International Molecular Biology

Sosei Heptares and Captor Therapeutics Enter Strategic Technology Collaboration Focused on Targeted GPCR Degradation as Novel Approach for Drug Design

The Pharma Data

DECEMBER 21, 2020

Program focused on identifying small molecules that target a GPCR for degradation as potential therapeutic agents for gastrointestinal disorders. Unique combination of novel technologies to enhance GPCR drug discovery and expand capabilities into wider drug target universe. ” Michal J.

Targeted Protein Degradation

Targeted Protein Degradation Small Molecule Structure Based Drug Design (SBDD) Drugs

Drug Discovery Digest

Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

Sosei Heptares and Captor Therapeutics Enter Strategic Technology Collaboration Focused on Targeted GPCR Degradation as Novel Approach for Drug Design

Stay Connected